Medicover AB (publ)

Medicover AB (publ)

0RPS · London Exchange

Medicover AB (publ) (0RPS) is a Medical equipment services company in the Healthcare sector, listed on London Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Medicover AB (publ) in 2026. The next earnings report is expected on November 4, 2026.

Earnings calendar

Next earnings date

04 Nov 2026

In 77 days

EPS estimate

0.20

Revenue estimate

738.7M

Past earnings

22 Jul 2026
EPS actual
0.19 (+3.2%)
estimate 0.19
Revenue actual
731.4M (+0.4%)
estimate 728.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
29 Apr 2026
EPS actual
0.17 (+20.7%)
estimate 0.14
Revenue actual
721.1M (+0.7%)
estimate 715.8M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
10 Feb 2026
EPS actual
0.15 (+4.6%)
estimate 0.15
Revenue actual
718.4M (-0.5%)
estimate 721.8M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Medicover AB (publ) beat consensus estimates in its latest earnings report, with EPS of usd 0.1942 coming in 3.2% above expectations and revenue of usd 731.38 million exceeding estimates by 0.4%. Both EPS and revenue were also ahead of expectations in the previous report.

Dividend calendar

Next ex-dividend

—

Not scheduled

Next payment

—

Not scheduled

Dividend amount

—

Not available

Past dividends

Ex-dividend Payment Amount
30 Apr 2026 11 May 2026 0.23

EPS (Earnings Per Share)

Revenue

Dividend per share

Company profile

Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Sector
Healthcare
Industry
Medical equipment services
Country
Sweden
Exchange
London Exchange
CEO
John Paul Stubbington
Employees
47,000
IPO date
30 May 2017
ISIN
SE0009778848
Website
medicover.com

Frequently asked questions

When does Medicover AB (publ) (0RPS) next report earnings?

Medicover AB (publ) (0RPS) is scheduled to report earnings on November 4, 2026.

What was Medicover AB (publ)'s most recent earnings date?

Medicover AB (publ) (0RPS) last reported earnings on July 22, 2026.

Where is Medicover AB (publ) stock listed?

Medicover AB (publ) (0RPS) is listed on London Exchange.